Amylin Pharmaceuticals, Inc.
Records under this name other than the patents Amylin Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Back to Amylin Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,293,871 | Poly(LACTIDE-CO-GLYCOLIDE) Based Sustained Release Microcapsules Comprising a Polypeptide and a Sugar Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,721,615 | Ampoule comprising an ampoule holder Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,535,659 | Engineered Polypeptides Having Enhanced Duration of Action Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,329,648 | Methods for Treating Diabetes and Reducing Body Weight Term ended Term ended Aug 18, 2026 · High confidence | Term ended | Term ended Aug 18, 2026 | High confidence |
| US 8,906,851 | Method for Treating Diabetes Term ended Term ended Aug 18, 2026 · High confidence | Term ended | Term ended Aug 18, 2026 | High confidence |
| US 9,884,092 | Methods for Treating Diabetes and Reducing Body Weight Term ended Ended no later than Aug 18, 2026 · Medium confidence | Term ended | Ended no later than Aug 18, 2026 | Medium confidence |
| US 8,895,498 | GIP and exendin hybrid polypeptides Term ended Term ended Feb 10, 2026 · USPTO record | Term ended | Term ended Feb 10, 2026 | USPTO record |
| US 9,238,076 | Polymer-Based Sustained Release Device Term ended Ended no later than Jun 22, 2025 · Medium confidence | Term ended | Ended no later than Jun 22, 2025 | Medium confidence |
| US 9,593,154 | Engineered polypeptides having enhanced duration of action Lapsed on the fee record Ended Mar 14, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 14, 2025 | USPTO record |
| US 7,563,871 | Polymer-Based Sustained Release Device Formerly held Term ended Ended no later than Apr 15, 2024 · Medium confidence | Term ended | Ended no later than Apr 15, 2024 | Medium confidence |